Products with THC reduced pain a little across multiple trials, but those that were mostly CBD didn't outperform placebos.

Ambros Therapeutics launches with $125M to advance neridronate, a non-opioid therapy for CRPS-1. See how this Phase 3-ready ...

Cannabis products with higher THC levels may slightly reduce chronic pain, particularly nerve pain, according to a review of ...

SereNeuro Therapeutics revealed promising results for SN101, a first-in-class iPSC-derived therapy designed to treat chronic osteoarthritis pain while protecting joint tissue. Instead of blocking pain ...

A new stem cell–based therapy challenges traditional pain treatment by using pain-sensing neurons to reduce inflammation and protect joints. Newly released preclinical data describes an unconventional ...

After two decades of surgeries, prescriptions, and debilitating symptoms, this mom discovered a treatment that significantly ...

There’s a new option to help patients with chronic pain. NeuraLace Medical has received FDA clearance for its Axon Therapy, a technology that non-invasively stimulates peripheral nerves and provides ...

Experts highlight “nociplastic pain,” a newly defined pain mechanism changing how chronic pain is understood and treated Many chronic pain patients suffer not from damage, but from a sensitized ...

Genicular Artery Embolization (GAE) represents a new paradigm in treating knee osteoarthritis that had hitherto been handled ...

A new review paper co-authored by two Johns Hopkins pain experts suggests that scrambler therapy, a noninvasive pain treatment, can yield significant relief for approximately 80%–90% of patients with ...

Pain represents the cardinal symptom of osteoarthritis, yet its intensity, quality, and impact vary dramatically among ...

"Let's do it," Shelly Spears told her doctor. "I can no longer live like this." The "it" in this case was a procedure in which doctors would anesthetize an area of her back and then burn off a chunk ...